Wilzar Fachri

Wilzar Fachri

Auto-generated profile, based on publicly available information

Wilzar Fachri

Department of Medical Pharmacy, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, Jakarta 10430, Indonesia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2026 in Indonesian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
PAPedro Anugerah Aswan
Pedro Anugerah Aswan
BMBaitha Palanggatan Maggadani
Baitha Palanggatan Maggadani
WFWilzar Fachri
Wilzar Fachri
Raditya IswandanaRaditya Iswandana
Raditya Iswandana
The development of robust analytical methods is essential for quality control of nanoethosomal formulations containing asiaticoside and α-mangostin, bioactive compounds with anti-inflammatory and antioxidant properties. Simultaneous quantification within nanocarriers is challenging and requires validated techniques. This study established a precise HPLC method, in accordance with ICH Q2(R2) guidelines, for the concurrent determination of both compounds. The technique demonstrated excellent linearity (R2 > 0.999), precision (%RSD < 2%), and accuracy (95–105% recovery). The nanoethosomal system also achieved high encapsulation efficiencies of 94.76% for asiaticoside and 99.27% for α-mangostin. This validated method provides a reliable tool for standardizing these complex nano-formulations, supporting their further development and clinical translation.